Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  OpGen, Inc.    OPGN

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about OPGEN, INC.
12/01OPGEN : Corporate Presentation (PDF)
PU
12/01OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Pres..
GL
11/24OPGEN : Announces $10 Million Private Placement Priced at the Market
AQ
11/24OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
GL
11/13OPGEN : Corporate Presentation (PDF)
PU
11/12OPGEN : Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Test..
AQ
11/12OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic ..
GL
11/11OPGEN : Reports Third Quarter 2020 Financial Results and Provides Business Updat..
AQ
11/11OpGen Reports Third Quarter 2020 Financial Results and Provides Business Upda..
GL
10/29OPGEN : to Provide Business Update and Financial Results for the Third Quarter 2..
AQ
10/29OpGen to Provide Business Update and Financial Results for the Third Quarter ..
GL
10/28OPGEN : Announces Award of German Government Grant Funding to its Subsidiary Cur..
AQ
10/28OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
10/27OPGEN : Corporate Presentation (PDF)
PU
10/15OPGEN : Provides Business and Pipeline Update and Announces Preliminary Unaudite..
AQ
10/15OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudit..
GL
10/13OPGEN : Issues Formal Response to FDA's Requests for Additional Information and ..
AQ
10/13OpGen Issues Formal Response to FDA's Requests for Additional Information and..
GL
10/06OPGEN : Corporate Presentation (PDF)
PU
10/05OPGEN : Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud
AQ
10/05OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-g..
GL
09/30OPGEN : Announces Award of German Government Grant Funding to its Subsidiary Cur..
AQ
09/30OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
09/28OPGEN : Announces Successful Completion of Study Collaboration with Karolinska I..
AQ
09/28OpGen Announces Successful Completion of Study Collaboration with Karolinska ..
GL
09/18OPGEN : Announces Notice of Annual Meeting Venue Change
AQ
09/18OpGen, Inc. Announces Notice of Annual Meeting Venue Change
GL
09/16OPGEN : Collaborative Research by OpGen Group Company Ares Genetics and Johns Ho..
AQ
09/16Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins..
GL
09/14OPGEN : Corporate Presentation (PDF)
PU
09/08OPGEN : Ares Genetics Nominated for Austrian Innovation Award for AI-powered Mol..
AQ
09/08OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for..
GL
09/02Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Trac..
GL
08/20OPGEN : Corporate Presentation (PDF)
PU
08/20OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Dev..
GL
08/12OpGen Reports Second Quarter 2020 Financial Results and Provides Business Upd..
GL
08/11OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant ..
GL
08/09OpGen Co-Markets COVID-19 Antibody Test Kit
GL
08/05OpGen to Provide Business Update and Financial Results for the Second Quarter..
GL
07/15OpGen Provides Business Update and Announces Preliminary Unaudited Revenue an..
GL
07/13Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CE..
GL
07/09OPGEN : Subsidiary Curetis GmbH Secures Access to Additional EUR 5.0 Million Non..
AQ
07/07OPGEN : Corporate Presentation (PDF)
PU
06/09OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneum..
GL
06/03OpGen Expands Partnership with New York State Department of Health and IDC to..
GL
05/11OpGen CEO and Chairman of the Board Issue Letters to Stockholders
GL
05/07OpGen Reports First Quarter 2020 Financial Results and Provides Business Upda..
GL
04/27OpGen to Provide Business Update and Financial Results for the First Quarter ..
GL
04/21OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study ..
GL
04/16OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next..
GL
04/14OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Qua..
GL
04/01OpGen and Curetis Successfully Close their Business Combination Transaction
GL
03/30CURETIS N : OpGen Announces Shareholder Approval for Business Combination with C..
AQ
03/24OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provide..
GL
03/24OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the ..
GL
03/23OpGen Data Predicting Phenotypic Antimicrobial Susceptibility Published in Di..
GL
03/19OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business..
GL
03/16OpGen Provides Update on Curetis Now Offering BGI's CE-IVD Rapid Test Kit for..
GL
03/12OpGen to Provide Business Update and Financial Results for the Fourth Quarter..
GL
03/10Curetis N.V. Shareholders Approve Planned Business Combination with OpGen
GL
02/20OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combin..
GL
02/12OPGEN : Announces Preliminary Unaudited Revenue for Fiscal 2019 and Provides Bus..
AQ
01/30OpGen Provides Update on Curetis Group Company Ares Genetics' Collaboration w..
GL
01/28OpGen Achieves Key Milestone in Planned Business Combination with Curetis
GL
2019OpGen Provides Update on Curetis Group Business Receiving U.S. FDA 510(k) Cle..
GL
2019OpGen Provides Curetis Group Business Update and Announces Completion of Key ..
GL
2019OpGen Products in Development to Address “Urgent Threat” Pathogen..
GL
2019OpGen Reports Third Quarter 2019 Financial Results and Provides Business Upda..
GL
2019OpGen Provides Update on Curetis Group Company Ares Genetics Business
GL
2019OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call
GL
2019OpGen Announces Closing of $9.4 Million Underwritten Public Offering
GL
2019U.S. Patent Allowed Covering Acuitas Lighthouse® Software
GL
2019OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary..
GL
2019OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics ..
GL
2019OpGen Provides update on Curetis Group's R&D Collaboration
GL
1  2Next
Upcoming event on OPGEN, INC.